Remove 2009 Remove Access Remove Chronic Pain Remove Clinical Trials
article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Le-Short C.,

article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

3 A 2009 study touched on the trigeminal system as well, examining the connection between the CB1 gene (called CNR1) and people who reported migraines. 5 THC and migraines THC is well-known for its anti-nausea and pain-relieving effects. Ethan Russo details the historical use of cannabis for migraines.

Terpenes 132
article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. It became illegal in the US in 2009. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. As such, there have been numerous clinical trials using ketamine.

History 119
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

article thumbnail

Article: Canada: Future Care Costs For Cannabis In Personal Injury Claims

Cannabis Law Report

Despite the recent legalization of cannabis, a framework for access to cannabis for medical purposes still exists, but under new regulations passed under the authority of the Cannabis Act. Poirier sued following a surgical procedure that left her with chronic pain and limitations affecting her lifestyle and career. ” 42.